Project Information

Pipeline

Research goal

  • DTaP

    Development of trivalent combination vaccines against diphtheria, tetanus, and pertussis (DTaP); Penta/hexa-valent vaccines against haemophilus influenza type B(HiB), polio(IPV), hepatitis B =(HepB), etc.

    • Candidate verification → (TRL 4) → Non clinical trial → Phase 1 → Phase 2
  • Japanese Encephalitis

    Ensuring advanced vaccine technologies by revamping the safety and the production process

    • Candidate verification → (TRL 4) → Non clinical trial → Phase 1 → Phase 2
  • Hepatitis A

    Development of vaccines with improved efficacy and stability

    • Candidate verification → Non clinical trial → Phase 1 → Phase 2
  • Human Papilloma Virus

    Development of vaccines against metastatic cancer-related diseases, including cervical cancer and head and neck cancer

    • Candidate verification → Non clinical trial → Phase 1 → Phase 2

Participants